Clinical validation of molecular markers of macrocyclic lactone resistance in Dirofilaria immitis

Prophylaxis with macrocyclic lactone (ML) endectocides is the primary strategy for heartworm control. Recent evidence has confirmed that ML-resistant Dirofilaria immitis isolates have evolved. Comparison of genomes of ML-resistant isolates show they are genetically distinct from wild-type population...

Full description

Bibliographic Details
Main Authors: Cristina Ballesteros, Cassan N. Pulaski, Catherine Bourguinat, Kathy Keller, Roger K. Prichard, Timothy G. Geary
Format: Article
Language:English
Published: Elsevier 2018-12-01
Series:International Journal for Parasitology: Drugs and Drug Resistance
Online Access:http://www.sciencedirect.com/science/article/pii/S2211320718300666
id doaj-28998fc64dd640ada85848cf42f56d21
record_format Article
spelling doaj-28998fc64dd640ada85848cf42f56d212020-11-25T01:53:37ZengElsevierInternational Journal for Parasitology: Drugs and Drug Resistance2211-32072018-12-0183596606Clinical validation of molecular markers of macrocyclic lactone resistance in Dirofilaria immitisCristina Ballesteros0Cassan N. Pulaski1Catherine Bourguinat2Kathy Keller3Roger K. Prichard4Timothy G. Geary5Institute of Parasitology, McGill University, 21111 Lakeshore Road, Sainte Anne de Bellevue, H9X 3V9, QC, Canada; Corresponding author.School of Veterinary Medicine, Louisiana State University, Skip Bertman Drive, Baton Rouge, LA, 70803, USAInstitute of Parasitology, McGill University, 21111 Lakeshore Road, Sainte Anne de Bellevue, H9X 3V9, QC, CanadaInstitute of Parasitology, McGill University, 21111 Lakeshore Road, Sainte Anne de Bellevue, H9X 3V9, QC, CanadaInstitute of Parasitology, McGill University, 21111 Lakeshore Road, Sainte Anne de Bellevue, H9X 3V9, QC, Canada; Corresponding author.Institute of Parasitology, McGill University, 21111 Lakeshore Road, Sainte Anne de Bellevue, H9X 3V9, QC, Canada; Corresponding author.Prophylaxis with macrocyclic lactone (ML) endectocides is the primary strategy for heartworm control. Recent evidence has confirmed that ML-resistant Dirofilaria immitis isolates have evolved. Comparison of genomes of ML-resistant isolates show they are genetically distinct from wild-type populations. Previously, we identified single nucleotide polymorphisms (SNPs) that are correlated with phenotypic ML resistance. Since reliable in vitro assays are not available to detect ML resistance in L3 or microfilarial stages, the failure to reduce microfilaraemia in infected dogs treated with an ML has been proposed as a surrogate clinical assay for this purpose. The goal of our study was to validate the genotype-phenotype correlation between SNPs associated with ML resistance and failure to reduce microfilaraemia following ML treatment and to identify a minimal number of SNPs that could be used to confirm ML resistance. In this study, 29 participating veterinary clinics received a total of 148 kits containing supplies for blood collection, dosing and prepaid shipping. Patients recruited after a diagnosis of heartworm infection were treated with a single standard dose of Advantage Multi® and a blood sample taken pre- and approximately 2–4 weeks post-treatment. Each sample was processed by performing a modified Knott's Test followed by isolation of microfilariae, genomic DNA extraction and MiSeq sequencing of regions encompassing 10 SNP sites highly correlated with ML resistance. We observed significant correlation of SNP loci frequencies with the ML microfilaricidal response phenotype. Although all predictive SNP combination models performed well, a 2-SNP model was superior to other models tested. The predictive ability of these markers for ML-resistant heartworms should be further evaluated in clinical and epidemiological contexts.http://www.sciencedirect.com/science/article/pii/S2211320718300666
collection DOAJ
language English
format Article
sources DOAJ
author Cristina Ballesteros
Cassan N. Pulaski
Catherine Bourguinat
Kathy Keller
Roger K. Prichard
Timothy G. Geary
spellingShingle Cristina Ballesteros
Cassan N. Pulaski
Catherine Bourguinat
Kathy Keller
Roger K. Prichard
Timothy G. Geary
Clinical validation of molecular markers of macrocyclic lactone resistance in Dirofilaria immitis
International Journal for Parasitology: Drugs and Drug Resistance
author_facet Cristina Ballesteros
Cassan N. Pulaski
Catherine Bourguinat
Kathy Keller
Roger K. Prichard
Timothy G. Geary
author_sort Cristina Ballesteros
title Clinical validation of molecular markers of macrocyclic lactone resistance in Dirofilaria immitis
title_short Clinical validation of molecular markers of macrocyclic lactone resistance in Dirofilaria immitis
title_full Clinical validation of molecular markers of macrocyclic lactone resistance in Dirofilaria immitis
title_fullStr Clinical validation of molecular markers of macrocyclic lactone resistance in Dirofilaria immitis
title_full_unstemmed Clinical validation of molecular markers of macrocyclic lactone resistance in Dirofilaria immitis
title_sort clinical validation of molecular markers of macrocyclic lactone resistance in dirofilaria immitis
publisher Elsevier
series International Journal for Parasitology: Drugs and Drug Resistance
issn 2211-3207
publishDate 2018-12-01
description Prophylaxis with macrocyclic lactone (ML) endectocides is the primary strategy for heartworm control. Recent evidence has confirmed that ML-resistant Dirofilaria immitis isolates have evolved. Comparison of genomes of ML-resistant isolates show they are genetically distinct from wild-type populations. Previously, we identified single nucleotide polymorphisms (SNPs) that are correlated with phenotypic ML resistance. Since reliable in vitro assays are not available to detect ML resistance in L3 or microfilarial stages, the failure to reduce microfilaraemia in infected dogs treated with an ML has been proposed as a surrogate clinical assay for this purpose. The goal of our study was to validate the genotype-phenotype correlation between SNPs associated with ML resistance and failure to reduce microfilaraemia following ML treatment and to identify a minimal number of SNPs that could be used to confirm ML resistance. In this study, 29 participating veterinary clinics received a total of 148 kits containing supplies for blood collection, dosing and prepaid shipping. Patients recruited after a diagnosis of heartworm infection were treated with a single standard dose of Advantage Multi® and a blood sample taken pre- and approximately 2–4 weeks post-treatment. Each sample was processed by performing a modified Knott's Test followed by isolation of microfilariae, genomic DNA extraction and MiSeq sequencing of regions encompassing 10 SNP sites highly correlated with ML resistance. We observed significant correlation of SNP loci frequencies with the ML microfilaricidal response phenotype. Although all predictive SNP combination models performed well, a 2-SNP model was superior to other models tested. The predictive ability of these markers for ML-resistant heartworms should be further evaluated in clinical and epidemiological contexts.
url http://www.sciencedirect.com/science/article/pii/S2211320718300666
work_keys_str_mv AT cristinaballesteros clinicalvalidationofmolecularmarkersofmacrocycliclactoneresistanceindirofilariaimmitis
AT cassannpulaski clinicalvalidationofmolecularmarkersofmacrocycliclactoneresistanceindirofilariaimmitis
AT catherinebourguinat clinicalvalidationofmolecularmarkersofmacrocycliclactoneresistanceindirofilariaimmitis
AT kathykeller clinicalvalidationofmolecularmarkersofmacrocycliclactoneresistanceindirofilariaimmitis
AT rogerkprichard clinicalvalidationofmolecularmarkersofmacrocycliclactoneresistanceindirofilariaimmitis
AT timothyggeary clinicalvalidationofmolecularmarkersofmacrocycliclactoneresistanceindirofilariaimmitis
_version_ 1724990111177768960